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Objective: To examine if chest pain increases the risk of depression and anxiety, or, on the 
other hand, depression and anxiety increase the risk of chest pain onset in patients with 
coronary heart disease (CHD). 
Design: Prospective clinical study. 
Setting: 16 general practices in the Greater London Primary Care Research Network. 
Participants: 803 participants with a confirmed diagnosis of CHD at baseline on the Quality 
and Outcomes Framework (QOF) CHD registers. 
Main outcome measures: Rose Angina Questionnaire, HADS depression and anxiety 
subscales and PHQ-9 were assessed at seven time points, each 6 months apart. Multi-Level 
Analysis (MLA) and Structural Equation Modelling (SEM) were applied. 
Results: Chest pain predicts both more severe anxiety and depression symptoms at all time 
points until 30 months after baseline. However, although anxiety predicted chest pain in the 
short term with a strong association, this association did not last after 18 months. Depression 
had only a small, negative association with chest pain.  
Conclusions: In persons with CHD, chest pain increases the risk of both anxiety and 
depression to a great extent. However, anxiety and depression have only limited effects on the 
risk for chest pain. This evidence suggests that anxiety and depression tend to be 
consequences rather than causes of cardiac chest pain. Intervention studies that support 
persons with CHD by providing this information should be devised and evaluated, thus 















Coronary heart disease (CHD) is the number one cause of death worldwide.[1] Clinically, it is 
mainly characterized by chest pain.[2] Chest pain in a patient with known CHD could signify 
new or unresolved issues with the coronaries. Biopsychosocial issues such as social isolation, 
adverse life events, chronic health conditions, coping mechanisms, distress, anxiety, or 
depression may also play a role, as either the consequence or the cause of the chest pain. 
Several studies have shown that especially comorbid depression and anxiety frequently co-
occur with chest pain cross-sectionally.[3-6] It is also clear that this comorbidity has a 
substantial additional impact on quality of life,[7] even when depression or anxiety are in 
remission.[4,8]  
The relationship may be two-sided. Longitudinal epidemiological research shows overall 
associations between psychological problems and chest pain. In patients with CHD, chest pain 
increases the risk of occurrence of a new depression more than 3-fold.[9] Chest pain is also 
associated with patients exhibiting 3-year chronic symptomatology of distress, as compared to 
patients with low chest pain symptoms throughout the same period.[10] The finding that 
patients with a depressive disorder are also at increased risk of developing CHD supports a 
bidirectional association.[11-13] Furthermore, in a meta-analysis the association between 
anxiety and risk of CHD in healthy individuals was explored.[14] The results of this study 




Given the possibly bidirectional association between chest pain and depression and anxiety in 
patients with CHD, so far it remains unknown which factor contributes mostly to onset of the 
other. The question remains whether chest pain contributes to the onset of depression and 
anxiety more, or, the other way around, that depression and anxiety contribute to the onset of 
chest pain in patients with CHD more. A precise understanding of which factor is the 
strongest predictor in this association would be highly relevant to support decisions in clinical 













The aim of this longitudinal study is to examine if chest pain increases the risk of depression 
and/or anxiety, or, on the other hand, if depression and anxiety increase the risk of the onset 




Study design and Setting 
Details of the cohort study protocol have been reported elsewhere.[15] The sampling frame 
comprised people on the Quality and Outcomes Framework (QOF) CHD registers kept by 
participating general practices. The Greater London Primary Care Research Network recruited 
sixteen General Practices from the inner city and suburban south London. Recruitment and 
baseline assessments were completed during 2008-2009.  
 
Participants 
The cohort was described in more detail elsewhere.[16] The sampling focus of the main 
study, of which data was used for the present study, was on patients with CHD. General 
practitioners are remunerated for keeping CHD registers under the QOF. Practices 
participating in this Framework and based in South London were recruited by the London 
Primary Care Research Network (PCRN). Recruitment was based on an ‘opt-in’ procedure. 
All patients on the CHD registers in participating general practices were firstly invited by the 
practices themselves to participate in the study. Those agreeing to be contacted were put 
through to the research team, who gave them further information about the study and provided 
a consent form. Consenting patients were assessed at baseline and then every six months over 
a 3-year period. Written, informed consent was obtained for all participants before the initial 
assessment was conducted. Ethical approval was granted through the Bexley and Greenwich 
Research Ethics Committee (REC reference number: 07/H0809/38).  
 
Measures 
Specific to this analysis, the measures of interest were the following: 
 
Rose Angina Questionnaire 
A modified version of the Rose Questionnaire[17] was used at baseline and all follow-up 
assessments to assess the presence and symptoms of chest pain. The modification consisted 











occurred. At baseline the time period evaluated was one year before baseline. At each follow-
up visit, the occurrence of chest pain since the previous visit was assessed. Published in 1962 
with the purpose of detecting angina pectoris in field studies,[17] the Rose Questionnaire has 
been widely used to determine the prevalence of angina and CHD in a large number of 
epidemiological studies across the world. The short version of the questionnaire was 
developed as some aspects of the original were deemed possibly redundant. It was established 
that a quick, three question method could just as efficiently detect the crucial predictive 
component of mortality: exertional pain.[18] Similar to past studies using the full version to 
identify patients with ‘non-exertional pain’ and ‘exertional pain’,[19] the short version of the 
Rose Questionnaire allows for this classification with just three questions. For the purposes of 
the UPBEAT-UK cohort, the chest pain categorical variable comprised three groups: ‘no 
pain’, ‘exertional pain’, and ‘non-exertional pain’.[16] These three categories were also used 
for the present study. Participants who did not report having chest pain were classified as 
having ‘no chest pain’. Participants who did report having chest pain, but not when hurrying, 
walking uphill, etc. were classified as having ‘nonexertional chest pain’. Participants who 
reported chest pain that occurred on exertion (i.e. when hurrying, walking uphill, etc.) were 
classified as having ‘exertional chest pain’. 
 
Hospital Anxiety and Depression Scale (HADS) 
Participants completed the 14-item HADS,[20] originally intended to identify symptoms 
regarding the emotional component of a psychical illness, by distinguishing them from those 
physical items that may be caused by the physical condition itself. The one-factor scale was 
then divided into two separate scales of seven items each. The HADS scores the severity of 
depressive and anxiety symptoms, both subscales ranging from 0 to 21. These subscales of the 
HADS are well-validated and provide a probable diagnosis of depression (HADS-D) or 
anxiety (HADS-A) for those scoring above the cut point of 8, established as the optimal cut-
off for detecting clinically significant symptoms of depression and anxiety.[21] The cut-off 
score for severe levels of depression or anxiety is 12. Thus, scores of 8-11 represent a 
clinically significant, possible diagnosis of depression or anxiety, and scores of 12 and higher 
represent a clinically significant, probable diagnosis of depression or anxiety. The HADS has 
been extensively validated[22] and both subscales of the HADS have a good internal 
consistency (Cronbach’s alpha for HADS-D ranges from 0·67 to 0·90; Cronbach’s alpha for 
HADS-A ranges from 0·68-0·93).[21] The HADS has been widely used in people with 












Patient Health Questionnaire (PHQ-9) 
The PHQ-9 was used to assess the severity of depressive symptoms. The PHQ-9 is a brief, 
validated instrument, consisting of 9 items, that scores each of the DSM-IV criteria for Major 
Depressive Disorder.[26] Each item is scored from 0 (not at all) to 3 (nearly every day). The 
total score thus varies from 0 to 27, with higher scores indicating higher levels of depressive 
symptoms. Scores of 0-5, 6-10, 11-15, and 16-20 represent mild, moderate, moderately 




Age, gender, ethnicity, relationship status, employment status, and educational level. 
 
Time points 
All measures were reported at seven time points, each six months apart, from t0 (baseline) to 
t6 (36 months). These were recoded to the number of months, for example, t24 = follow up at 
24 months after baseline. 
 
Data Analysis 
DEMOGRAPHIC AND BASELINE CHARACTERISTICS 
First, initial data analysis was performed on the whole data set, to explore demographic 
variables and baseline characteristics.  
 
Next, the analyses consisted of 3 steps. For step 1 (multilevel analysis), the questionnaires 
were used as a categorized variable. For steps 2 and 3 (structural equation modelling), the 
questionnaires were used as a continuous variable. 
 
Step 1: as a first step, multilevel analysis (MLA) was performed to assess the variability at the 
practice level, to assess interdependence of variables over trajectories of time, and to assess 
the usefulness of the variables for incorporation in the next phase in which structural equation 
modelling (SEM) was planned. Three-valued recoded variables (PHQ-9, HADS-A and 
HADS-D) were only used in the MLA which were aimed at getting a first impression of the 
one-way relationships with the Rose Questionnaire. Practices, demographic variables, as well 











9) were taken into account. The Rose Questionnaire was considered to be ordinal and the 
transformation suggested by Rasbash et al.[28] was applied to use it as a dependent variable 
in the multilevel models. For PHQ-9, HADS-A and HADS-D, we used the categorised scores. 
All three have three ordered categories, and the same transformation as for the Rose 
Questionnaire was used to be able to use them as dependent variables. The original 
categorised scores were used when these variables were used as independents in the models. 
We first used a model with 3-levels (Time point, Patient and Practices). This analysis showed 
that although there was some variation between the general practices, this variation was not 
associated with the outcomes. Hence a 2-level MLA model could be run leaving the practice 
level out of the model and keeping only the time point and patient level. As age, ethnicity, and 
relationship had no significant association with the Rose Questionnaire, PHQ-9, HADS-D and 
HADS-A, and gender, employment, and education showed an association, the latter were 
included in all multilevel models. HADS-D varied insufficiently for the values of the Rose 
Questionnaire to study the correlation of the latter with all time points. Hence HADS-D was 
not included in subsequent models. Thus, we only used PHQ-9 to represent depression, and 
HADS-A to represent anxiety.  
 
Step 2: at step 2 structural equation modelling (SEM) was performed, for which the 
questionnaires were used as a continuous variable (in contrast to the use of the questionnaires 
as categorized variables in the MLA in step 1). For structural equation models, it is essential 
that respondents have data at all time points. We used the cross-validation approach described 
in Adèr & Mellenbergh[29] to be able to assess the stability of our models. We started by 
randomly dividing the data into two datasets, A and B. Next, a three-step procedure was 
followed:  
First, modelling was done on dataset A. Only full cases were used, that is, respondents from 
whom data was collected at all seven time points. This provided two models: (a) One in which 
the Rose Questionnaire is used to predict HADS-A and depression as measured with the 
PHQ-9 at later time points and, (b) a model in which both PHQ-9 and HADS-A predict the 
Rose Questionnaire at later time points. As a sensitivity analysis, once these models were 
established, in a second step, they were verified using dataset B. This procedure was followed 
to be able to check the stability and validity of the resulting models.  
Step 3: as a third step, the estimates in the final SEMs were refined using data of respondents 











For this step, the following procedure was followed, for the models in which anxiety (HADS-
A) and depression (PHQ-9) were explored: 
1.  We started from the model fitted on the second half of the dataset of subjects who were 
present at all measurement points (baseline to 36 months). 
2.  We did a series of analyses, adding respondents that had all measurements up to month 30, 
month 24, month 18, month 12, month 6, and baseline (in that order). Note that the 
respondents present in later analyses were always present in analyses with fewer time points 
(Thus, patients present in the 36-month analysis were present in all analyses). 
3.  Of each analysis, we used the estimates of arrows to and from the last time point to 
enhance the 36-months analysis. For the model exploring the association between chest pain 
and anxiety and depression, all time points were used. 
4.  As a fourth step, estimates for the time point corresponding to 36 months were left out as 
they were inconsistent between the analyses in the first modelling phase and the verification 
phase. The final models thus used the usual coding for PHQ-9 and HADS-A and have 30 
months as their last time point.  
As this is a longitudinal study, not a clinical trial, there are no events between time points that 
were planned in the design of the study. Therefore, it was sufficient to consider the predictive 
power of the Rose Questionnaire, HADS-A, and PHQ-9 at the first time point. Consequently, 
the term ‘lost-to-follow-up’ is not applicable here. In fact, in this study, data of cases with 




The sample is extensively described elsewhere.[9] Eight hundred three people participated 
(figure 3). Of this sample, 95.9% had a diagnosis of coronary artery disease (42.2% had a 
documented history of myocardial infarction and 53.7% a diagnosis of ischaemic heart 
disease or angina). The remaining 4.1% on the CHD register had a primary diagnosis of 
arrhythmia, heart failure, or not-specified. Of the total sample, 18.5% (149/803) met the 
criteria for an ICD-10 defined diagnosis of a depressive or an anxiety disorder; 6.7% (54/803) 
met criteria for depressive disorder and 3.2% (26/803) for anxiety disorder. Demographic 
variables and baseline characteristics are given in Table 1. Most participant were male 
(69.9%), mean age was 71.1. The association between individual levels of the Rose 
questionnaire and the anxiety and depression measurements turns out to be comparable for all 












Table 1: Baseline characteristics of the total sample (N=803) 
Demographic variables
a   
Gender, n (%) Male 561 (69.9) 
 Female 242 (30.1) 
Age, mean (SD)  71·1 (10.9) 
Education, n (%) < 2 years 376 (46.8) 
 > 2 years 415 (51.7) 
Employment, n (%) Unemployed 30 (3.7) 
 Paid work 148 (18.4) 
 Retired 619 (77.1) 
O utcome variables
a   
ROSE questionnaire, n (%)
 
No chest pain 299 (37.2) 
 Exertional chest pain 94 (11.7) 
 Non-exertional chest pain 143 (17.8) 
PHQ-9, n (%)
 
None or mild depressive symptoms 510 (63.5) 
 Moderate depressive symptoms 155 (19.3) 
 Severe depressive symptoms 136 (16.9) 
HADS anxiety score, n (%)
 
<8  No clinically significant anxiety symptoms 650 (80.9) 
 8-11 Clinically significant, possible diagnosis of 
anxiety 
79 (9.8) 
 >11 Clinically significant, probable diagnosis of 
anxiety 
71 (8.8) 
Abbreviations: SD = standard deviation; PHQ-9 = patient health questionnaire; HADS = hospital anxiety and 
depression scale 
a
N differs due to missing data 
Numbers are based on the correction of variables in the preliminary analysis.  
 
Results of the SEM analysis are shown in Figures 1 and 2. As mentioned before, we used a 
cross-validation approach to assess the stability of the models. Figures 1 and 2 show the 
models found in the verification step of the SEM analysis. Only the structural model is shown. 
Coefficients in the Figures are standardized scores and in most cases coefficients < 0.1 have 
been left out. Figure 1 shows the prediction of anxiety and depressive symptoms by chest 











depressive at all time points. The associations in the model obtained in the verification step of 
the modelling process (using data set B) correspond to those obtained in the first step in which 
dataset A was used. The observed associations are high, ranging from 0.89 to 0.95.  
 
Figure 1: Chest pain estimated by Rose predicting Anxiety estimated by HADS Anxiety and Depression estimated by PHQ9 
(coefficients are standardized sores). Legend: CP0: Chest pain at time point zero; ANXi: Anxiety at time point i; DEPi: 
Depression at time point i. 
 
Figure 2 gives the prediction of chest pain by anxiety and depressive symptoms. Although 
more severe symptoms of anxiety were associated with chest pain in the first few timepoints 
(up to 18 months), this association did not last. More severe symptoms of depression had a 
strong negative association with chest pain at baseline (-0.81) and at six months (-0.415), and 
only a small, negative association (-0.143) with chest pain after 24 months. Several links in 
the model obtained in the first step of the modelling process (using dataset A) had to be left 
out during the verification step (using data set B) since associations did not correspond. In 




Figure 2: Depression estimated by PHQ9 and Anxiety estimated by HADS Anxiety predicting the occurrence of Chest pain 
estimated by Rose (coefficients are standardized scores). Legend: CP0, DEP0, ANX0: Chest pain, Depression and Anxiety at 
time point zero; CPi: Chest pain at time point i. 
 
DISCUSSION 
Our study shows that in patients with CHD, chest pain at baseline contributes to the onset of 











coefficients around 0.9, than the other way around. Depression and anxiety at baseline have 
only limited effects on the risk for onset of chest pain. Regarding the direction of the 
relationship between chest pain and depression or anxiety, our results suggests that clinically 
significant more severe symptoms of depression and anxiety tend to be consequences of the 
pain rather than causes of it.  
Anxiety only has a short-term effect on chest pain, and depression seems to have a small 
protective effect against chest pain. One interpretation for this finding might be that 
medication could play a role in this. Beta blockers are frequently used in case of chest pain in 
CHD, in which fatigue is a common adverse effect; this might play a role in the level of 
physical activity, and hence the amount of experienced chest pain. Unfortunately, the level of 
physical activity was not available in this sample, so this possibility could not be explored. 
Also, research indicates that beta-blockers are associated with less depressive symptoms in 
patients with cardiac disorders.[30,31] This might explain the slight ‘protective’ effect on 
chest pain that was found in case of depression. Unfortunately, the use of medication in this 
sample was not available for analysis, so this possibility could not be further explored and this 
should be a topic for further research.  
 
Generalisability 
All the patients in this study were recruited from primary care CHD registers in the South 
London region. If patients were only at risk for CHD and not diagnosed as such, they were not 
in the register. Patients with no chest pain in this study still had CHD, probably somewhat 
under control due perhaps to a previous intervention, such as coronary artery bypass graft. 
Most patients were long-term CHD patients, who had had the usual treatments and 
medications. Hence, these study results apply to an urban population with CHD and more or 
less chest pain, which is primarily treated by their general practitioner. 
 
Limitations of the study 
The HADS-D subscale turned out to be unstable to such an extent in the preliminary MLA 
that it could not be used for analysis. This may be in line with the findings of a systematic 
review, which established that the ability of the HADS to differentiate between anxiety and 
depression is unclear.[32] The validity of the HADS to discern depression and anxiety from 
each other by its subscales has been subject to extensive debate in the literature[33] and our 
finding that the PHQ9 performed better is in line with such earlier findings. Fortunately, in 











validation enabled us to develop a stable structural model. The PHQ-9 includes items such as 
fatigue and sleeping too much, which might refer to the somatic component of depression but 
also to regular symptoms of CHD or as a side effect of medication. Hence we do not expect a 
particular bias in any direction. 
Another limitation is that this study is based on longitudinal cohort data that do not allow for 
controlling all theoretically possible factors that might play a role in causality, as it is not 
possible to randomize for such factors in a cohort study. No data were collected of 
pharmacotherapy or comorbid conditions, among others, which may have had an impact on 
the level of pain or psychological wellbeing of the patient. Moreover, in a qualitative study in 
a small sub-sample (n=30) of the UPBEAT study, patients reported a variety of themes which 
might impact the association between chest pain and depression and anxiety, such as social 
isolation, medical illness and disability, adverse life events, and coping mechanisms,[34] 
which might influence the association between chest pain and depression and anxiety. 
However, this is the first study that allows assuming a direction of causality, taking this 
limitation into account. The lack of data on physical activity is another limitation of this 
study. Anxiety and depression have its effect on physical exertion. For example, persons who 
are anxious about their cardiovascular symptoms, are more likely to avoid physical exertion. 
Furthermore, persons with a depression are more likely to be less active. In both cases, these 
persons are protected from exertional chest pain. Future research needs to take this into 
account. Furthermore, most participants in this study did not have a clinically diagnosed 
depressive or anxiety disorder at baseline. As a consequence, we were unable to test whether a 
possible relationship exists of chest pain with severity (measured with the HADS) of  
diagnosed depression and anxiety. 
 
Clinical implications 
This is a finding of high clinical relevance. Patients with CHD fearing that worries might lead 
to increased symptomatology and thus worsening of the experience of their condition, can be 
assured that there is an insufficient ground for such fears. That may be a relief for patients 
fearing cardiac deterioration because of depressive or anxiety symptoms. Cardiologists and 
general practitioners can play an important role in assuring their patients. The core idea would 
be to help people deal with their chest pain symptoms and fatigue. To help them discern 
which chest pain would be a reason to visit the doctors for further investigation and how to 
tease these physical and psychological symptoms apart. Counselling patients and providing 











may be an adequate approach given these findings. In a qualitative study in the UPBEAT 
sample, most participants found talking therapies and interventions providing the opportunity 
for social interaction, support and exercise, such as Cardiac Rehabilitation, to be helpful 
whereas anti-depressants were not favoured.[34] Also, how to become or remain active and 
not give in to possibly paralysing feelings of demoralisation, and, last but not least, help 
patients alleviating possible feelings of guilt would be helpful. Such treatments could be 
delivered by trained general practice nurses or psychotherapists providing this in the context 
of Cognitive and Behavioural Therapy,[35] Acceptance and Commitment Therapy[36] or 
metacognitive therapy.[37] Hence, the findings of this study pertain to multiple professional 
audiences.  
Research implications 
Now that this study established that chest pain seems to primarily pose a risk for developing 
anxiety and depression and not the other way around, intervention studies should be devised 
and evaluated that support patients with CHD in coping with their chest pain at a 
psychological level. A qualitative study in the context of this study revealed that patients had 
issues with sexual problems, employment problems, and financial problems, besides their 
health problems.[38] Coming to terms not only with dealing with the chest pain in a de-
catastrophizing way but also with these problems, may be required as the focus of new 
interventions. Further research is also needed to explore the role of other, biopsychosocial, 
factors (e.g. cardiac medication, physical activity, coping strategies, attachment style) in the 
interface of chest pain and anxiety and depression in CHD. 
 
Conclusion 
Psychological problems are the consequence rather than the cause of chest pain in primary 
care patients with stable CHD.  
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Chest pain, depression and anxiety in coronary heart disease: consequence or cause? A prospective 
clinical study in primary care 
 803 primary care patients with CHD were followed-up every 6 months for 3 years. 
 Chest pain predicts symptoms of anxiety and depression in the long term. 
 Symptoms of anxiety predict chest pain only in the short term. 
 Symptoms of depression might be a protective factor for chest pain. 
 Anxiety and depression tend to be consequences of pain rather than causes of it. 
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